A retrospective NIS to evaluate the use of Seroquel XR and IR in the clinical practice of outpatients with schizophrenia
Study identifier:NIS-NDK-SER-2010/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A retrospective, non-interventional study to evaluate the use of Seroquel XR and Seroquel IR in the clinical practice of outpatients with schizophrenia
Medical condition
schizophrenia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
186
Study type
Observational
Age
18 Years - 65 Years
Date
Study Start Date: 01 Oct 2010
Primary Completion Date: 01 Feb 2011
Study Completion Date: 01 Feb 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Mar 2011 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 300 patients Female or male aged 18-65 years with a diagnosis of schizophrenia having received at least one dose of Seroquel XR or Seroquel IR during January – March 2010 | - |
Contacts
Investigators
Principal Investigator
Eva Dencker Vansvik
AstraZeneca Nordic-Södertälje, Sweden
